SCHEMBL13596272

SCHEMBL13596272

Fc1ccc([C@H]2CC3CCC2N3)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.72
CHRNA4 P43681 6/20 0.72
CHRNA7 P36544 4/20 0.72
CHRNB4 P30926 3/20 0.72
CHRNA3 P32297 3/20 0.72
ALDH1A1 P00352 2/20 0.72
MEN1 O00255 1/20 0.72
KMT2A Q03164 1/20 0.72
CHRNA1 P02708 1/20 0.72
CHRNG P07510 1/20 0.72
CHRNB1 P11230 1/20 0.72
HPGD P15428 1/20 0.72
CHRND Q07001 1/20 0.72
CHRNA2 Q15822 1/20 0.72
TDP1 Q9NUW8 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663147 1.00 CHRNB2 (0.72) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL14682057 0.91 CHRNB2 (0.74) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
(+)-Epibatidine SCHEMBL316977 0.84 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
(-)-Epibatidine SCHEMBL2500147 0.84 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
Epibatidine SCHEMBL29390446 0.84 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
Epibatidine SCHEMBL9070584 0.84 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
Epibatidine SCHEMBL316978 0.84 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL7957936 0.83 CHRNB2 (0.70) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL8045774 0.83 CHRNB2 (0.70) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL13632123 0.83 CHRNB2 (0.70) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4617043-A1 LIQUID CONTAINING DEVICE FOR 3D PRINTING AND 3D PRINTER Zhejiang Xunshi Technology Co., Ltd. (CN) 2025-09-17 EP claimed
CN-222692211-U Light glass-based photovoltaic module 安徽天柱绿色能源科技有限公司 2025-03-28 CN claimed
CN-111913387-B System for redundancy and load balancing of multiple acquisition devices based on soft bus 卡斯柯信号有限公司 2025-03-25 CN claimed
CN-118507569-A High-strength ultrathin photovoltaic power generation device 安徽天柱绿色能源科技有限公司 2024-08-16 CN claimed
WO-2024098479-A1 LIQUID CONTAINING DEVICE FOR 3D PRINTING AND 3D PRINTER 浙江迅实科技有限公司 2024-05-16 WO claimed
CN-118024575-A Liquid containing tank for 3D printing and 3D printer 浙江迅实科技有限公司 2024-05-14 CN claimed
WO-2024083199-A1 FEEDING MECHANISM, 3D PRINTER AND 3D PRINTING METHOD 广州黑格智造信息科技有限公司 2024-04-25 WO claimed
CN-117621339-A Production process of high oxygen permeability elastic NFEP release film 昆山飞云光学材料有限公司 2024-03-01 CN claimed
CN-116277935-A Method for printing CT bulb tube high-capacity rotary target disc packaging box by adopting SLA technology 安庆瑞迈特科技有限公司 2023-06-23 CN claimed
CN-218948449-U Liquid containing tank for 3D printing and 3D printer 浙江迅实科技有限公司 2023-05-02 CN claimed
CN-218948441-U Liquid containing device for 3D printing and 3D printer 浙江迅实科技有限公司 2023-05-02 CN claimed
CN-115648623-A Feeding mechanism, 3D printer and 3D printing method 广州黑格智造信息科技有限公司 2023-01-31 CN claimed
WO-2025136836-A9 HYDRAULIC 3D-PRINTING SYSTEM AND METHOD SPRINTRAY, INC. (US) 2026-05-21 WO disclosed
EP-4733043-A1 PULSING RELEASE MODULE, PULSING RELEASE RESIN TANK, AND 3D PRINTING DEVICE AND PRINTING METHOD Guangzhou Heygears IMC. Inc (CN) 2026-04-29 EP disclosed
EP-4650151-A1 THREE-DIMENSIONAL PRINTING APPARATUS AND THREE-DIMENSIONAL PRINTING METHOD Guangzhou Heygears IMC. Inc (CN) 2025-11-19 EP disclosed
US-20250332785-A1 Three-Dimensional Printing Apparatus and Three-Dimensional Printing Method GUANGZHOU HEYGEARS IMC. INC (CN) 2025-10-30 US disclosed
CN-115648623-A Feeding mechanism, 3D printer and 3D printing method 广州黑格智造信息科技有限公司 2023-01-31 CN disclosed
EP-4066178-A1 METHODS AND SYSTEMS FOR COMPONENT-BASED REDUCED ORDER MODELING FOR INDUSTRIAL-SCALE STRUCTURAL DIGITAL TWINS Akselos S.A. (CH) 2022-10-05 EP disclosed
US-20090318490-A1 COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION RESEARCH TRIANGLE INSITUTE (US) 2009-12-24 US disclosed
US-7615567-B2 Compounds and methods for promoting smoking cessation RESEARCH TRIANGLE INSTITUTE (US) 2009-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318490-A1 COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION BHMT2, CBS, NNMT CHRNB2 297/4885CHRNA4 605/4885CHRNA7 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.